Interaction of the Adenovirus Type 5 E4 Orf3 Protein with Promyelocytic Leukemia Protein Isoform II Is Required for ND10 Disruption

Por Hoppe, Anne, Beech, Stephanie J., Dimmock, John, Leppard, Keith N.
Publicado em 2006

Interstitial 12p deletion involving more than 40 genes in a patient with postnatal microcephaly, psychomotor delay, optic nerve atrophy, and facial dysmorphism()

Por Hoppe, Anne, Heinemeyer, Jan, Klopocki, Eva, Graul-Neumann, Luitgard M., Spors, Birgit, Bittigau, Petra, Kaindl, Angela M.
Publicado no Meta Gene (2014)

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the...

Por Paton, Nicholas I, Kityo, Cissy, Thompson, Jennifer, Nankya, Immaculate, Bagenda, Leonard, Hoppe, Anne, Hakim, James, Kambugu, Andrew, van Oosterhout, Joep J, Kiconco, Mary, Bertagnolio, Silvia, Easterbrook, Philippa J, Mugyenyi, Peter, Walker, A Sarah
Publicado no Lancet HIV (2017)

HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa

Por Kityo, Cissy, Thompson, Jennifer, Nankya, Immaculate, Hoppe, Anne, Ndashimye, Emmanuel, Warambwa, Colin, Mambule, Ivan, van Oosterhout, Joep J., Wools-Kaloustian, Kara, Bertagnolio, Silvia, Easterbrook, Philippa J., Mugyenyi, Peter, Walker, A. Sarah, Paton, Nicholas I.
Publicado no J Acquir Immune Defic Syndr (2017)

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up resu...

Por Hakim, James G, Thompson, Jennifer, Kityo, Cissy, Hoppe, Anne, Kambugu, Andrew, van Oosterhout, Joep J, Lugemwa, Abbas, Siika, Abraham, Mwebaze, Raymond, Mweemba, Aggrey, Abongomera, George, Thomason, Margaret J, Easterbrook, Philippa, Mugyenyi, Peter, Walker, A Sarah, Paton, Nicholas I
Publicado no Lancet Infect Dis (2018)